Mid Cycle review of the BLA (STN[removed])

First Page		Document Content
Coagulation system Anticoagulants ATryn Genetic engineering Goats Antithrombin III deficiency Deep vein thrombosis Antithrombin Pulmonary embolism Hematology Blood Health		Mid Cycle review of the BLA (STN[removed]) Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 210,02 KB Share Document on Facebook

	Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave. DocID: 1riKA - View Document
	Microsoft Wordfile00 DocID: 1r9dZ - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	RECOTHROM, Thrombin topical (Recombinant) Package Insert DocID: 1qv5K - View Document
	Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve DocID: 1qk7W - View Document